AP NEWS
ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Chiral Chromatography Column (Empty, Prepacked, Analytical, Preparative) Market - Global Forecast to 2025 - ResearchAndMarkets.com

December 21, 2020 GMT

DUBLIN--(BUSINESS WIRE)--Dec 21, 2020--

The “Chiral Chromatography Column Market by Technology (GC, LC, TLC, Flash Chromatography), type (Empty, Prepacked, Analytical, Preparative), Material (Metal, Glass, Plastic), Enduser (Hospital, Food, Pharma-Biotech, Environmental - Global Forecast to 2025” report has been added to ResearchAndMarkets.com’s offering.

ADVERTISEMENT

The chiral chromatography column market size is projected to reach USD 123 million by 2025 from an estimated USD 99 million in 2020, at a CAGR of 4.5% during the forecast period.

Increasing R&D investments in the pharmaceutical and biotechnology industry is creating demand opportunities for the chiral chromatography column industry.

Also, the increasing importance of chromatography tests for drug approvals is driving the chiral chromatography column market globally. However, the lack of skilled professionals and high instrumentation costs hinder the growth of chiral chromatography columns.

The pharmaceutical & biotechnology companies segment, by the end user, is expected to be the largest and the fastest-growing market from 2020 to 2025.

Pharmaceutical & biotechnology companies account for the largest share in the chiral chromatography column market in 2019. The adoption of analytical instrumentation during various stages of biopharmaceutical and pharmaceutical drug discovery, drug research and development, pharmacokinetics, toxicology, and clinical studies drive the growth of the market in the industrial sector.

Increasing R&D for therapeutic areas, such as cancer, HIV/AIDS, and immunodeficiency disorders, technological innovations in biotechnology research, increasing focus of pharmaceutical and biotechnology companies on extending their product pipeline, rising number of drug discovery and clinical trial projects, and patent expiry of blockbuster drugs and biomolecules are some of the key factors driving the growth of this segment during the forecast period.

The liquid chromatography segment, by technology, is expected to be the fastest-growing market from 2020 to 2025.

Increasing demand for quick and efficient separation of chemical compounds drives the liquid chromatography column market growth. Liquid chromatography (LC), the first form of chromatography to be introduced, is the most widely used form due to its flexibility and functionality. LC is used for the separation of macromolecules and ionic species of biomedical interest, labile natural products, and a wide variety of high-molecular-weight and less stable compounds such as proteins, polysaccharides, synthetic polymers, nucleic acids, plant pigments, and surfactants.

ADVERTISEMENT

North America: The fastest growing region in the chiral chromatography column industry.

North America has a diverse and well-established R&D infrastructure, with the rapid adoption of chromatography techniques among end-user industries. North America accounted for the largest market share in the chiral chromatography columns market in 2019. A number of factors, such as increasing drug development activities, the availability of government funding for life science R&D, high adoption of technologically advanced solutions, and a large number of ongoing clinical research studies are driving the growth of the North American chiral chromatography columns market globally.

The chiral chromatography column market is dominated by a few major players that have an extensive country presence such as Agilent Technologies (US), Thermo Fisher Scientific (US), Waters Corporation (US), Daicel Corporation (Japan), Bio-Rad Laboratories(US), W.R.Grace & Co. (US), Merk Group (Germany), GL Sciences(Japan), Perkin Elmer (US), Shimadzu Corporation (Japan), Sartorious Group (Germany), Cytiva (US), ES Industries (US), and Phenomenex (US).

Market Dynamics

Drivers

  • Increasing R&D Investments in the Pharmaceutical and Biotechnology Industry
  • Increasing Importance of Chromatography Tests for Drug Approvals
  • Technological Advancements in Chromatography Instruments

Restraints

  • Lack of Skilled Professionals
  • High Instrumentation Costs

Opportunities

  • Growth Opportunities in Emerging Countries
  • Green Chromatography

Challenges

  • Inadequate Infrastructure for Research in Emerging Countries

Key Industry Trends

  • Rising Focus on Miniaturized Chiral Separation Techniques

Global Regulatory Guidelines

COVID-19 Impact Trends on the Global Market

Companies Mentioned

  • Agilent Technologies
  • Bio-Rad Laboratories
  • Cytiva
  • Daicel Corporation
  • Es Industries
  • Fortis Technologies
  • Gl Sciences, Inc.
  • Hamilton Company
  • Hichrom Limited
  • Jasco
  • Merck KGaA
  • Perkinelmer
  • Phenomenex
  • Regis Technologies
  • Sartorius Group
  • Shimadzu Corporation
  • Thermo Fisher Scientific
  • W. R. Grace & Co.
  • Waters Corporation
  • YMC

For more information about this report visit https://www.researchandmarkets.com/r/bpsngb

View source version on businesswire.com:https://www.businesswire.com/news/home/20201221005319/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH GENERAL HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2020.

PUB: 12/21/2020 05:33 AM/DISC: 12/21/2020 05:33 AM

http://www.businesswire.com/news/home/20201221005319/en